Journal of Clinical Oncology (JCO) Podcast

JCO Article Insights: Lymph Node Dissection for Lung Cancer

JCO Article Insights: IMS-IMWG Consensus on High-Risk Multiple Myeloma

JCO Article Insights: Pooled Taletrectinib Efficacy and Safety

JCO at ASCO Annual Meeting: Neoadjuvant Osimertinib for Resectable EGFR-Mutated NSCLC

JCO at ASCO Annual Meeting: Avelumab Plus Cetuximab vs. Avelumab in Advanced cSCC

JCO at ASCO Annual Meeting: TTFields in Locally Advanced Pancreatic Adenocarcinoma

JCO at ASCO Annual Meeting: Use of Low-Value Cancer Treatments in Medicare

JCO at ASCO Annual Meeting: Lenvatinib Plus Pembrolizumab and Chemotherapy in Gastric Cancer

JCO Article Insights: Double Hit Myeloma Correlates With Adverse Patient Outcome

Pembrolizumab and Bevacizumab for Melanoma Brain Metastases

JCO Article Insights: ESPAC4 Long-Term Follow-Up in Pancreatic Cancer

Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment

JCO Article Insights: Smoking Assessment

Botensilimab Plus Balstilimab in Advanced Sarcomas

JCO Article Insights: Long-Term Outcome of Neoadjuvant Chemotherapy for Rectal Cancer

High Omega-3, Low Omega-6 Diet with Fish Oil and Prostate Cancer

JCO Article Insights: TROPION-Lung01 Dato-DXd in NSCLC

Air Pollution and Breast Cancer Incidence

JCO Article Insights: Adoption of Capivasertib in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer – Efficacy, Toxicity and Treatment Sequencing

Overcoming Barriers to Make Patient-Partnered Research a Reality

JCO Article Insights: Nivolumab + Relatlimab v Nivolumab + Ipilimumab in Melanoma

Quality of Treatment Selection

JCO Article Insights: HLA-Mismatched Unrelated Donor HCT With PTCy

Adjuvant Pembrolizumab for High-Risk, dMMR Endometrial Cancer

Combining Response and Toxicity Data to Implement Project Optimus

CBT-I for Cancer-Related Cognitive Impairment

JCO Article Insights: Assisted Reproduction in Breast Cancer Patients

Multi-Cancer Early Detection Testing for High-Risk Patients

JCO Article Insights: Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade

Functional Disability Among US Cancer Survivors

CAR T-Cell Therapy for Richter’s Transformation

EAZ171: Predictors of TIPN in Black Women with Breast Cancer

JCO Article Insights: Final Analysis of the Ro-CHOP Trial

Methylphenidate for Fatigue in Advanced Cancer

Introducing JCO Oncology Advances with Dr. Jonathan Friedberg and Dr. Pamela Kunz

JCO Article Insights: Atezolizumab Plus Bevacizumab, Chemotherapy in EGFR, ALK NSCLC

Commonly Held Beliefs About Cancer Survivorship

JCO Article Insights: Long Term Follow Up of the RESORT (E4402) and LYSA Study

Pembrolizumab in Patients With Advanced Cancers With HTMB

JCO Article Insights: Axillary Soft Tissue Involvement and Breast Cancer Prognosis

Omission of Radiotherapy after Breast-Conserving Surgery

Costs of Cancer Prevention in CDH1 Variant Carriers

JCO Article Insights: Low and Moderate Grade Adverse Events and the Patient Experience in Clinical Trials

Debunking Sex and Disentangling Gender From Oncology

Germline EGFR Mutations and Familial Lung Cancer

JCO Article Insights: DYPD-Guided Dose Individualization and Survival Outcomes

Negative Impact of Prior Authorization on Patients with Cancer

Role of Molecular Classification in Predicting Response to Radiation in Early Endometrial Cancer

JCO Article Insights: Impact of Physical Activity on Mortality and of BMI on Treatment-Related Adverse Events

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial